CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (NASDAQ: GENZ) announced today that Ron Branning, a 30-plus year bio/pharmaceutical veteran specializing in the development of world-class drug and device quality monitoring systems and regulatory compliance management practices, has joined the company as Senior Vice President of Global Product Quality. In this role, he will ensure the quality of all Genzyme products manufactured at seventeen sites around the world.
